Phase 1-ready biotech developing antibody therapies for inflammatory diseases.
Industry: Health Care
Latest Trade: $47.25 0.00 (0.0%)
First Day Return: +24.9%
Return from IPO: +177.9%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/22/2023 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 17.7 |
Deal Size ($mm) | $300 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/13/2023 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 17.7 |
Deal Size ($mm) | $300 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Jefferies |
TD Cowen |
more |
Company Data | |
---|---|
Headquarters | Waltham, MA, United States |
Founded | 2022 |
Employees at IPO | 25 |
Website www.apogeetherapeutics.com |